Nationwide Developer and Distributor of Eye Care Solutions
Eye Care Therapy Developer and Distributor in the Southeast US
On NextCompany since September 30, 2026 (15 days)
Location undisclosed
Business overview
The company develops and distributes adjunctive eye care therapies from the Southeast US. It serves eye care professionals nationwide and reaches consumers through direct-to-patient e-commerce. Its CRM supports patient delivery without requiring providers to hold inventory. Gross revenue totaled $8,505,953, with EBITDA of $442,052.
No single customer contributed more than 5% of 2024 revenue. A nearby third party manufactures powdered supplements in runs as small as 50 units. The company uses approximately 59% of a 25,000-square-foot facility and sublets the balance. An affiliated landlord offers a facility sale or long-term lease.
Who is a good fit for this business
- Strategic acquirers in eye care supplies seeking a distribution channel that serves eye care professionals nationwide.
- E-commerce operators seeking a direct-to-patient eye care business with CRM-supported delivery.
Details
- Reason for selling
- The owners are seeking to reduce financial risk and pursue other business opportunities.
- Real estate
- Leased
Frequently Asked Questions
The company develops and distributes adjunctive eye care therapies. It serves eye care professionals nationwide and sells directly to consumers through e-commerce.
The business reports gross revenue of $8,505,953 and EBITDA of $442,052. No single customer contributed more than 5% of 2024 revenue.
A nearby third party manufactures the powdered supplements. That manufacturer accepts production runs as small as 50 units.
The company uses approximately 59% of a 25,000-square-foot facility and sublets the balance. An affiliated landlord offers a facility sale or long-term lease.
The owners seek to reduce their financial risk. They also plan to pursue other business opportunities.